ZYMEWORKS INC. Stock Issued During Period, Shares, Conversion of Convertible Securities
ZYMEWORKS INC. (ZYME) had Stock Issued During Period, Shares, Conversion of Convertible Securities of 3.79 million shares as of 2022-08-23, per its 10-K filed 2023-03-07.
Discontinued
us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities · last filed 2023-03-07
- 2022-08-23: Stock Issued During Period, Shares, Conversion of Convertible Securities 3.79M shares.
| Period end | Stock Issued During Period, Shares, Conversion of Convertible Securities |
|---|---|
| 2022-08-23 | 3.79M shares 10-K · filed 2023-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |